Trials / Sponsors / Rubius Therapeutics
Rubius Therapeutics
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | RTX-224 Monotherapy in Patients With Solid Tumors Non Small Cell Lung Cancer, Cutaneous Melanoma, Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2022-01-12 |
| Terminated | RTX-321 Monotherapy in Patients With HPV 16+ Tumors Cervical Cancer, Head and Neck Cancer, Anal Cancer | Phase 1 | 2021-04-08 |
| Terminated | RTX-240 Monotherapy and in Combination With Pembrolizumab Solid Tumor, AML Adult | Phase 1 / Phase 2 | 2020-05-06 |
| Terminated | Safety and Tolerability of RTX-134 in Adults With Phenylketonuria Phenylketonurias | Phase 1 | 2020-01-29 |